Skip to main content
Clinical Trials/CTRI/2021/06/034068
CTRI/2021/06/034068
Completed
未知

POSTOPERATIVE ANALGESIC EFFECT OF INTRAPERITONEAL ROPIVACAINE WITH AND WITHOUT MAGNESIUM SULFATE IN LAPAROSCOPIC CHOLECYSTECTOMY-A PROSPECTIVE OBSERVATIONAL STUDY

DNB Resident Dissertation No financial support0 sites44 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: K819- Cholecystitis, unspecified
Sponsor
DNB Resident Dissertation No financial support
Enrollment
44
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
January 11, 2022
Last Updated
3 years ago
Study Type
Interventional

Investigators

Sponsor
DNB Resident Dissertation No financial support

Eligibility Criteria

Inclusion Criteria

  • PATIENTS WHO ARE ASA CLASS 1 OR 2 UNDERGOING ELECTIVE LAPROSCOPIC SURGERY
  • BMI \-18 TO 30

Exclusion Criteria

  • PATIENT WITH ECG SHOWING CONDUCTION ABNORMALITIES
  • PREGNANT AND BREASTFEEDING
  • PATIENT ON BETA BLOCKERS
  • PATIENT WITH CHRONIC PAIN ON OPIOIDS AND OTHER ANALGESICS
  • HISTORY OF ALLERGY TO STUDY DRUGS
  • SURGERY DURATIONS MORE THAN THREE HOURS
  • CONVERSION TO OPEN PROCEDURE
  • EMERGENCY CHOLYCYSTECTOMY
  • PATIENTS REQUIRING COMMON BILE DUCT EXPLORATIO

Outcomes

Primary Outcomes

Not specified

Similar Trials